Clinical Trials Browser

Phase 1/2 × Photons × Genitourinary × Clear all

NCT06432036 2026-03-06

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

Phase 1/2 Recruiting

Carcinoma, Renal Cell